The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models
Abstract
Epidemiological studies in humans, as well as experimental studies in animal models, have shown an association between visceral obesity and dyslipidemia, insulin resistance, and type 2 diabetes mellitus. Recently, attention has been focused on the excessive accumulation of triglycerides (TG) in the liver as part of this syndrome. In this review, important principles of the pathophysiological involvement of the liver in the metabolic syndrome obtained in rodent models are summarized. We focus on non-alcoholic causes of steatosis, because the animal experiments we refer to did not include alcohol as an experimental condition. In general, there is continuous cycling and redistribution of non-oxidized fatty acids between different organs. The amount of TG in an intrinsically normal liver is not fixed but can readily be increased by nutritional, metabolic, and endocrine interactions involving TG/free fatty acid (FFA) partitioning and TG/FFA metabolism. Several lines of evidence indicate that hepatic TG accumulation is also a causative factor involved in hepatic insulin resistance. Complex interactions between endocrine, metabolic, and transcriptional pathways are involved in TG-induced hepatic insulin resistance. Therefore, the liver participates passively and actively in the metabolic derangements of the metabolic syndrome. We speculate that similar mechanisms may also be involved in human pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
In the citing paper
“Steatosis has often been associated with hepatic IR in the context of obesity [43].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling
SHEPHERD, P. R., WITHERS, D. J., & SIDDLE, K. (1998) · Biochemical Journal · doi:10.1042/bj3330471 · Cited by 953
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Coburn, C. T., Knapp, F. F., Febbraio, M., Beets, A. L., Silverstein, R. L., & Abumrad, N. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003826200 · Cited by 726
Shimomura, I., Bashmakov, Y. K., & Horton, J. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30028 · Cited by 704
Research works printed but not linked: 3
- 10.1161/atvb.21.12.2051 · DOI
- 10.1210/jcem.87.7.8638 · DOI · Paper page
- 2001, Int J Obes Relat Metab Disord, 25, S35
Cited by
Sorted by citations
Items 201–259 of 259
Fundamento molecular de la esteatosis hepática asociada a la obesidad
Buqué, X., Aspichueta, P., & Ochoa, B. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000900007 · Cited by 9
Guarneri, G., Palumbo, D., Pecorelli, N., Prato, F., Gritti, C., Cerchione, R., Tamburrino, D., Partelli, S., Crippa, S., Reni, M., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11946-x · Cited by 7
Association of [1H]-MRS quantified liver fat content with glucose metabolism status
Wang, Y.-S., Ye, J., Cao, Y., Zhang, R., Han, X.-F., Zou, L., Kuang, L., Zhang, J., Lian, H., Xia, J.-X., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00558-8 · Cited by 7
A(a)LS: Ammonia-induced amyotrophic lateral sclerosis
Parekh, B. K. (2015) · F1000Research · doi:10.12688/f1000research.6364.1 · Cited by 7
Macías‐Rodríguez, R. U., & Torre, A. (2009) · Revista de investigaci�n Cl�nica · Cited by 7
The role of cellular prion protein in lipid metabolism in the liver
Arora, A. S., Zafar, S., Latif, U., Llorens, F., Mihm, S., Kumar, P., Tahir, W., Thüne, K., Shafiq, M., Schmitz, M., et al. (2020) · Prion · doi:10.1080/19336896.2020.1729074 · Cited by 6
Bay, C., & El-Masri, H. A. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.02.002 · Cited by 6
Guiducci, L., Lionetti, V., Burchielli, S., Simi, C., Masi, S., Liistro, T., Pardini, S., Porciello, C., Cecco, P. D., Vettor, R., et al. (2011) · Endocrine Research · doi:10.3109/07435800.2010.534751 · Cited by 5
Drug discovery in the metabolic syndrome: context and some recent developments
Suckling, K. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.801 · Cited by 5
Keinosuke, I., Fujita, H., Kimura, N., Nagase, H., Wakasa, Y., Tsuruta, S., Muroya, T., & Hakamada, K. (2025) · Pancreas · doi:10.1097/mpa.0000000000002508 · Cited by 4
Fat Metabolism in Insulin Resistance and Type 2 Diabetes
Duez, H., & Lewis, G. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_4 · Cited by 4
The Cardiometabolic Syndrome and Liver Disease
Sowers, J. R. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.08248.x · Cited by 4
Cao, J., Qiu, W., Lin, Y., Liu, T., Dou, Z., & Chen, Z. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102406 · Cited by 4
Squalene: A Trove of Metabolic Actions
Ramírez‐Torres, A., Gabás‐Rivera, C., & Osada, J. (2016) · InTech eBooks · doi:10.5772/64384 · Cited by 4
Microarrays, antiobesity and the liver
Castro-Chávez, F. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32091-5 · Cited by 4
Why Less Diabetes with Blockade of the Renin-Angiotensin System?
Lau, T., Carlsson, P., & Leung, P. S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010019 · Cited by 4
Síndrome metabólico e inflamación
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., del Olmo, M. M., & Vidal, O. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73667-1 · Cited by 3
Wei, G., Rong, K., Yang, K., Bao, Z., Zhang, X., Zhang, Z., Gong, Y., & Wang, J. (2021) · Journal of Forestry Research · doi:10.1007/s11676-021-01380-2 · Cited by 3
RESTORATIVE EFFECT OF BETULA ALNOIDES BARK ON HEPATIC METABOLISM IN HIGH FAT DIET FED WISTAR RATS
Raj, A. D. A., Malarvili, T., & Velavans (2015) · International Journal of Pharma and Bio Sciences · Cited by 3
Wolf, D., Jehle, F., Rodríguez, A. O., Dufner, B., Hoppe, N., Colberg, C., Lozhkin, A. P., Bassler, N., Rupprecht, B., Wiedemann, A., et al. (2012) · PLoS ONE · doi:10.1371/annotation/84102aae-770a-41ae-9c15-4736ed129c17 · Cited by 3
Apaydın, T., Keklikkıran, Ç., Kani, H. T., Yilmaz, Y., & Yavuz, D. G. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02876-6 · Cited by 2
E-Abdalla, E.-E., El-Gharabawy, G. S., & El-Sawy, M. (2011) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2011.16412 · Cited by 2
The Liver, Glucose Homeostasis, and Insulin Action in Type 2 Diabetes Mellitus
Radziuk, J., & Pye, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_18 · Cited by 2
Yamada, Y., Noborisaka, Y., Ishizaki, M., Tsuritani, I., & Honda, R. (2004) · Environmental Health and Preventive Medicine · doi:10.1007/bf02898137 · Cited by 2
Ginneken, V., Ham, L., de Vries, E., & Verheij, E. R. (2016) · Anatomy & Physiology · doi:10.4172/2161-0940.1000233 · Cited by 2
Miao, Z., Yu, S., Zhang, Y., Yu, X., Sheng, H., Zhou, H., & Zhu, L. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2024.08.013 · Cited by 1
Rodríguez‐Gutiérrez, G., & de Roos, B. (2008) · Grasas y Aceites · doi:10.3989/gya.086308 · Cited by 1
Lin, S., & Hongxia, Z. (2011) · International Conference on Human Health and Biomedical Engineering · doi:10.1109/hhbe.2011.6029006 · Cited by 1
Western diet and/or lifestyle: is this a big health problem?
Kuneš, J. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.081505 · Cited by 1
Drug Treatment in the Metabolic Syndrome
Karathanasis, S. K., & SCHIEBINGER, R. J. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50027-9 · Cited by 1
Elariny, H. A., & Baranova, A. V. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.10.004 · Cited by 1
汐田剛史 (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.8 · Cited by 1
The effects of different types of dietary fats in the liver
Sim, P. Y. (2012) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 1
Transgenic Animal Models and the Metabolic Syndrome
Franckhauser, S., & Bosch, F. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50004-8
Lundgren, M. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Aspects involved in the (patho)physiology of the metabolic syndrome
Duivenvoorden, I. (2006) · Leiden Repository (Leiden University)
de Siqueira, É. R. F. (2011) · doi:10.11606/t.5.2011.tde-23112011-183723
pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Liu, Q., Bengmark, S., & Qu, S. (2010)
Martins, S. V. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Stéatose et résistance à l’insuline : implication des hépatokines
Bertrand, C., Valet, P., & Castan‐Laurell, I. (2015) · Obésité · doi:10.1007/s11690-015-0492-7
Hepatic Steatosis and TNF-α Signaling
Modi, N. (2007) · UWSpace (University of Waterloo)
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA MOTRICIDADE (ÁREA DE BIODINÂMICA DA MOTRICIDADE HUMANA)
Modelo, P. D., & Metabólica, S. (2008)
DJ-1 deficiency alleviates steatosis in cultured hepatocytes
Chaudhari, H. N., & Yun, J. W. (2015) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-015-0689-5
Microarray Analysis of Hepatic Genes Altered in Response to Olive Oil Fractions
Martínez-Gracia, M. V., & Osada, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374420-3.00125-x
Ng, T. (2007) · UWA Profiles and Research Repository (UWA)
Onyango, T. O., Dn, M., Ngugi, M. P., Kamau, J. K., & Juma, K. K. (2017) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.1000237
A Comprehensive Studies of an Indolizine-Based Seoul-Fluor System
Lee, Y. (2018) · Springer theses · doi:10.1007/978-981-13-1645-6_2
de Valparaíso, U., Mariane Lutz, R., Avaria, R., de Valparaíso, U., Luna, L., & de Valparaíso, U. (2018) · Perspectivas en Nutrición Humana · doi:10.17533/udea.penh.v20n1a02
Taher, J. (2017) · TSpace (University of Toronto)
Case Report of a Patient Diagnosed with Fatty Liver Accompanied by Hypertriglyceridemia
So-Young, H., An, S., Kim, E., Hwang, C.-H., Jang, E., Kim, Y., & Lee, J. H. (2021) · The Journal of Internal Korean Medicine · doi:10.22246/jikm.2021.42.2.207
Susana, Y., Suwanti, L. T., & Nangoi, L. (2021) · World s Veterinary Journal · doi:10.54203/scil.2021.wvj77
Sun, Y., Ni, W., Wang, D., Ren, J., Zhao, D., Yu, S., Liu, S., Zhang, S., Wang, S., Wang, W., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5124218
Wang, Y.-S., Ye, J., Cao, Y.-H., Zhang, R., Han, X.-F., Zou, L.-L., Kuang, L., Zhang, J., Lian, H., Xia, J.-X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12452345
Wang, Y.-S., Ye, J., Cao, Y.-H., Zhang, R., Han, X., Zou, L.-L., Kuang, L., Zhang, J., Lian, H., Xia, J.-X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12452351
Wang, Y.-S., Ye, J., Cao, Y.-H., Zhang, R., Han, X.-F., Zou, L.-L., Kuang, L., Zhang, J., Lian, H., Xia, J.-X., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12452354
Rôle de la protéine Gas6 et des cellules précurseurs dans la stéatohépatite et la fibrose hépatique
Fourcot, A. (2010) · theses.fr (ABES) · doi:10.70675/cfa04fd7z7fc5z4de1za21azd888d9c26d9b
Metadata
- Authors
- den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., & Romijn, J. A.
- Affiliations
- From TNO Prevention and Health (M.d.B., P.J.V., L.M.H.), Gaubius Laboratory Leiden, Leiden, The Netherlands; Department of Endocrinology and Diabetes (M.d.B., P.J.V., J.A.R.), Department of General Internal Medicine (L.M.H.), and Department of Cardiology (L.M.H.), Leiden University Medical Center, Leiden, The Netherlands; and Center for Liver, Digestive, and Metabolic Diseases (F.K.), Department of Pediatrics, University Hospital Groningen, Groningen, The Netherlands.
- Leiden University (NL)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2004-04
- Volume
- 24
- Issue
- 4
- Pages
- 644-649
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2160518844
- Cited by
- 260
- References
- 49
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 13 · 2016: 15 · 2015: 17 · 2014: 5 · 2013: 6 · 2012: 16
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- TNO Repository (submittedVersion)
- Repository hosted by TU Delft Library (TU Delft) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hepatic steatosis, metabolic syndrome, non-alcoholic fatty liver disease, triglyceride accumulation, hepatic insulin resistance, visceral obesity, dyslipidemia, type 2 diabetes, rodent models
- MeSH terms
- Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Dogs, Fatty Acids, Fatty Liver, Glucose, Homeostasis, Humans, Hyperlipidemias, Insulin Resistance, Liver, Models, Biological, Obesity, Rats, Zucker, Transcription, Genetic, Triglycerides, Models, Animal, Metabolic Syndrome, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
